Boston Scientific Corp. vs. NeuroOne Medical Technologies Corporation Common Stock
BSX
Boston Scientific Corp.
$43.92 -1.70%
VS NMTCNeuroOne Medical Technologies Corporation Common Stock
$1.33 +0.00%
Boston Scientific Corp. (BSX) comes out ahead, leading on 6 of 8 compared factors.
Size & Scale
| BSX | NMTC | |
|---|---|---|
| Market Cap | $63.65 billion | $12.11 million |
| Revenue (TTM) | $21.00 billion | $9.47 million |
| Net Income (TTM) | $3.67 billion | $-7,445,464 |
BSX leads on 3 of 3 size & scale factors.
Valuation
| BSX | NMTC | |
|---|---|---|
| P/E Ratio | 17.78 | — |
| Price / Book | 2.53 | 3.21 |
| Price / Sales | 3.03 | 1.28 |
BSX and NMTC split the valuation factors evenly.
Profitability
| BSX | NMTC | |
|---|---|---|
| Net Margin | 17.47% | -78.63% |
| Return on Equity | 14.57% | -197.62% |
BSX leads on 2 of 2 profitability factors.
Risk & Sentiment
| BSX | NMTC | |
|---|---|---|
| Short Interest | 0.72% | 0.00% |
NMTC leads on 1 of 1 risk & sentiment factors.
Dig deeper: BSX overview, BSX financials, NMTC overview, NMTC financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.